Skip to content

Author

M. Yasir

We have 2 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Dose-response efficacy and safety of the aldosterone synthase inhibitor baxdrostat in resistant hypertension: a systematic review and network meta-analysis.

Baxdrostat 1 mg and 2 mg significantly increased overall adverse events and hyperkalemia, whereas serious adverse events were not significantly increased, and both higher doses significantly increased hyperkalemia risk.

M. Shahzaib, Hafsa Ali, Muhammad Roshaan et al. · 0 citations
Open access Sep 2026

Global burden of thalassemia by socio-demographic index, 1990–2023: trends, disparities, and future implications

Thalassemia burden has declined substantially in high-SDI settings, driven by advances in prevention, screening, and treatment, but low and low-middle SDI regions continue to face rising absolute burdens and recent trend reversals, underscoring critical inequities in access to care.

F. Sawaira, S. H. Shahab, Madho Mal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.